20 results
8-K
EX-4.3
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent … of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
Stock issuable upon exercise of the Common Warrants.
“Company Counsel” means Foley & Lardner LLP, with offices located at 1 Independent Drive, Suite … of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
8-K
EX-4.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good … , or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
8-K
EX-4.2
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected … reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
by reference herein also contain estimates and other statistical data made by independent parties and by us relating to market size and growth … or modify such recommendations and has the right to obtain independent compensation advice. Neither the CEO nor any other members of management
8-K
EX-3.1
qyenagv iab
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm
8-K
6jsvsmqtuk uzdad
29 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:18pm
- Prev
- 1
- Next